Showing results (121-130 of 131) with videos related to

Sort By:
Pageof 14
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 7, 2021
Insights into kinetics, release, and behavioral effects of brain-targeted hybrid nanoparticles for cholesterol delivery in Huntington's diseaseGiulia Birolini, Marta Valenza, Ilaria Ottonelli, et al.
Scientific Reports|September 6, 2017
HIV-1 matrix protein p17 misfolding forms toxic amyloidogenic assemblies that induce neurocognitive disordersYasmin Zeinolabediny, Francesca Caccuri, Laura Colombo, et al.
Acta Neuropathologica Communications|January 28, 2025
Tau oligomers impair memory and synaptic plasticity through the cellular prion proteinClaudia Balducci, Franca Orsini, Milica Cerovic, et al.
Drugs in Context|April 17, 2026
Effectiveness of silymarin with lifestyle intervention in NAFLD and metabolic syndrome: a prospective single-arm studyWattana Sukeepaisarnjaroen, Roongruedee Chaiteerakij, Elvie Victonette Gonzalez, et al.
Science (New York, N.Y.)|March 17, 2009
A recessive mutation in the APP gene with dominant-negative effect on amyloidogenesisGiuseppe Di Fede, Marcella Catania, Michela Morbin, et al.
Pharmacological Research|June 19, 2023
Chronic cholesterol administration to the brain supports complete and long-lasting cognitive and motor amelioration in Huntington's diseaseGiulia Birolini, Marta Valenza, Ilaria Ottonelli, et al.
Pageof 14